Yahoo
Nasdaq - Delayed Quote USD

Driehaus Micro Cap Growth (DMCRX)

17.87 +0.39 (+2.23%)
At close: 8:05:50 AM EDT
Chart Range Bar
Loading chart for DMCRX
  • Previous Close 17.48
  • YTD Return 14.85%
  • Expense Ratio 1.34%
  • Category Small Growth
  • Last Cap Gain 30.00
  • Morningstar Rating
  • Morningstar Risk Rating --
  • Net Assets 520.67M
  • Beta (5Y Monthly) 1.57
  • Yield 0.22%
  • 5y Average Return --
  • Holdings Turnover 142.00%
  • Last Dividend 0.05
  • Inception Date Nov 18, 2013

The fund uses a growth style of investment in equity securities, including common stocks and other equity securities of issuers. Under normal market conditions, it invests at least 80% of its net assets (plus the amount of borrowings for investment purposes) in the equity securities of U.S. micro-capitalization ("micro-cap") companies. For purposes of the fund, the investment adviser considers a company to be a micro-cap company if it is within the same market capitalization range at the time of investment as those included in the Russell Microcap® Growth Index.

Driehaus

Fund Family

Small Growth

Fund Category

520.67M

Net Assets

2013-11-18

Inception Date

Performance Overview

View More

Trailing returns as of 10/26/2026. Category is Small Growth.

YTD Return

DMCRX
14.85%
Category
12.40%

1-Year Return

DMCRX
25.20%
Category
55.69%

3-Year Return

DMCRX
28.67%
Category
19.34%

5-Year Return

DMCRX
9.25%
Category
20.72%

People Also Watch

Holdings

View More

Top 10 Holdings (17.93% of Total Assets)

Symbol Company % Assets
Praxis Precision Medicines, Inc. 2.28%
Definium Therapeutics, Inc. 2.27%
Spyre Therapeutics, Inc. 2.04%
Bandwidth Inc. 1.89%
Amylyx Pharmaceuticals, Inc. 1.75%
Kiniksa Pharmaceuticals International, plc 1.65%
Xometry, Inc. 1.58%
Immunome, Inc. 1.55%
Adaptive Biotechnologies Corporation 1.47%
Edgewise Therapeutics, Inc. 1.44%

Sector Weightings

Top Mutual Funds

Mobilize your Website
View Site in Mobile | Classic
Share by: